acetyl-l-carnitine for leaky gut L-Carnitine and roles and neuroprotection in developing brain Acetyl-L-Carnitine – Mark Hyman, MD

Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kgelgen I, Li B, et al

Compared with the clinical drug tetramethylpyrazine hydrochloride, MAOE@TMP delivered drugs more efficiently and significantly reduced cerebral infarct volume (162)

This protective effect was associated with reduced ROS levels and increased intracellular GSH concentrations

prophylactic/therapeutic agents that can be used in accordance with the present invention are inhibitors of kinases such as, but are not limited to, ABL, ACK, AFK, AKT (e.g., AKT-1, AKT-2, and AKT-3), ALK, AMP-PK, ATM, Aurora1, Aurora2, bARK1, bArk2, BLK, BMX, BTK, CAK, CaM kinase, CDC2, CDK, CK, COT, CTD, DNA-PK, EGF-R, ErbB-1, ErbB-2, ErbB-3, ErbB-4, ERK (e.g., ERK1, ERK2, ERK3, ERK4, ERK5, ERK6, ERK7), ERT-PK, FAK, FGR (e.g., FGF1R, FGF2R), FLT (e.g., FLT-1, FLT-2, FLT-3, FLT-4), FRK, FYN one or more prophylactic/therapeutic agents that can be used in accordance with the present invention are inhibitors of Eph receptor kinases (e.g., EphA2, EphA4)

10.1111/apa.12735 Acta Paediatr

H Tr Bo V T Bo Trc Tc Nhn Mi Trng Trong bi cnh nhim khng kh, tia UV, khi bi v cc cht ha hc trong thc phm ngy cng gia tng, glutathione ng vai tr nh mt hng ro bo v gip t bo i ph vi cc tc nhn gy stress oxy ha t mi trng sng hng ngy